Lausanne, Switzerland





Job ID


Be a part of a revolutionary change Times are changing at PMI. We have chosen to do something big. The world expects us to act responsibly. And we are doing just that by transforming our business by building a smoke-free future and creating products with the power to improve the lives of a billion smokers worldwide. Wherever you join us, you will enjoy the freedom to dream up and deliver better, brighter solutions. It is the perfect setting place to start your career. Are you up for a 6-month challenge starting in February 2022? Then apply now, we are looking for you! Planning, Finance & Business Development Intern We are looking for you: • Currently studying for your degree in Business Administration, Finance, Management or relevant area • Good knowledge of Excel and PowerPoint • Pro-activity and drive for excellence coupled with curiosity and creativity • A fast learner, result-oriented • Ability to report to different stakeholders with various expectations • Some early experience in other Fast-Moving Consumer Goods a plus • Fluent in English, other local languages are an asset You will join a multicultural, dynamic and curious team of experts co-piloting the business and supporting the decision-making process by providing relevant analysis and scenarios, always keeping focus on our customers and ensuring accuracy of the financials. Roles & Objectives As an intern in Swiss market finance department, you will team up with the Planning and Finance team members and support them on various aspect of our business. Namely, you will contribute to deliver timely reports to our leadership team, be involved in ensuring that our internal controls are in place and be the one responsible for reflecting our latest actuals and forecasts in our global systems. On the other side, you will learn how the business runs at market level and how a market like Switzerland contributes at Regional and Global levels. You will have your first exposure to pricing, internal controls, reporting and ultimately to the market budget cycles. You will learn how competition may influence our tactics and how new generation products (RRPs* = Reduced Risk Products) can drive our local and global strategies. What we offer Our success depends on the men and women who come to work every single day with a sense of purpose and an appetite for progress. Join PMI and you too can: • Seize the freedom to define your future and ours. We will empower you to take risks, experiment and explore. • Be part of an inclusive, diverse culture, where everyone’s contribution is respected; collaborate with some of the world’s best people and feel like you belong. • Pursue your ambitions and develop your skills with a global business – our staggering size and scale provides endless opportunities to progress. • Take pride in delivering our promise to society: to improve the lives of a billion smokers. JOIN A GLOBAL MARKET LEADER PMI is the world’s leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products (“RRPs”). RRPs is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce far lower quantities of harmful and potentially harmful compounds than found in cigarette smoke. For more information, see and PMI is an Equal Opportunity Employer. *Reduced Risk Products (“RRPs”) is the term we use to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes. PMI’s RRPs are in various stages of development and commercialization, and we are conducting extensive and rigorous scientific studies to determine whether we can support claims for such products of reduced exposure to harmful and potentially harmful constituents in smoke, and ultimately claims of reduced disease risk, when compared to smoking cigarettes. Before making any such claims, we will rigorously evaluate the full set of data from the relevant scientific studies to determine whether they substantiate reduced exposure or risk. Any such claims may also be subject to government review and authorization, as is the case in the USA today.